{"filing":{"accession":"0001298709-26-000011","url":"/filing/0001298709-26-000011","form_type":"4","issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_name_source":null,"issuer_ticker":"KRYS","issuer_url":"/issuer/0001711279","period_of_report":"2026-09-04","filed_date":"2026-09-04","acceptance_dt":"2026-09-04T19:14:09+00:00","acceptance_label":"2026-09-04 19:14 UTC","ingested_at":"2026-09-05T05:24:49.724574+00:00","ingested_label":"2026-09-05 05:24 UTC","schema_version":null,"source":"Layline","parse_status":"parsed","parse_ok":true,"edgar_url":"https://www.sec.gov/Archives/edgar/data/1711279/0001298709-26-000011-index.htm","day_url":"/filings/2026-09-04"},"owners":[{"owner_cik":"0001298709","owner_name":"Krishnan Krish S","url":"/insider/0001298709","anchor":"owner-0001298709","role":"Director, Officer (President and CEO), Ten percent owner","officer_title":"President and CEO","is_director":true,"is_officer":true,"is_ten_percent":true,"is_other":false,"filing_anchor":"/filing/0001298709-26-000011#owner-0001298709"}],"line_owners":[{"owner_name":"Krishnan Krish S","role":"Director, Officer (President and CEO), Ten percent owner"}],"transactions":[{"id":9305444,"accession":"0001298709-26-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001298709-26-000011","line_url":"/filing/0001298709-26-000011#line-1","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298709","owner_name":"Krishnan Krish S","owner_display_name":"Krishnan Krish S","owner_url":"/insider/0001298709","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":520.0,"shares_display":"520","price_per_share":354.54,"price_display":"354.54","price_state":"stated","total_value":184360.8,"total_display":"184,360.80","total_whole":"184,361","shares_owned_after":1372023.0,"shares_owned_after_display":"1,372,023","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9305443,"accession":"0001298709-26-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001298709-26-000011","line_url":"/filing/0001298709-26-000011#line-2","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298709","owner_name":"Krishnan Krish S","owner_display_name":"Krishnan Krish S","owner_url":"/insider/0001298709","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2029.0,"shares_display":"2,029","price_per_share":355.5719,"price_display":"355.57","price_state":"stated","total_value":721455.3851,"total_display":"721,455.39","total_whole":"721,455","shares_owned_after":1369994.0,"shares_owned_after_display":"1,369,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9305442,"accession":"0001298709-26-000011","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001298709-26-000011","line_url":"/filing/0001298709-26-000011#line-3","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298709","owner_name":"Krishnan Krish S","owner_display_name":"Krishnan Krish S","owner_url":"/insider/0001298709","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3297.0,"shares_display":"3,297","price_per_share":356.3687,"price_display":"356.37","price_state":"stated","total_value":1174947.6039,"total_display":"1,174,947.60","total_whole":"1,174,948","shares_owned_after":1366697.0,"shares_owned_after_display":"1,366,697","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9305441,"accession":"0001298709-26-000011","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001298709-26-000011","line_url":"/filing/0001298709-26-000011#line-4","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298709","owner_name":"Krishnan Krish S","owner_display_name":"Krishnan Krish S","owner_url":"/insider/0001298709","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3981.0,"shares_display":"3,981","price_per_share":357.5738,"price_display":"357.57","price_state":"stated","total_value":1423501.2978,"total_display":"1,423,501.30","total_whole":"1,423,501","shares_owned_after":1362716.0,"shares_owned_after_display":"1,362,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9305440,"accession":"0001298709-26-000011","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001298709-26-000011","line_url":"/filing/0001298709-26-000011#line-5","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298709","owner_name":"Krishnan Krish S","owner_display_name":"Krishnan Krish S","owner_url":"/insider/0001298709","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3143.0,"shares_display":"3,143","price_per_share":358.4182,"price_display":"358.42","price_state":"stated","total_value":1126508.4026,"total_display":"1,126,508.40","total_whole":"1,126,508","shares_owned_after":1359573.0,"shares_owned_after_display":"1,359,573","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9305439,"accession":"0001298709-26-000011","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001298709-26-000011","line_url":"/filing/0001298709-26-000011#line-6","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298709","owner_name":"Krishnan Krish S","owner_display_name":"Krishnan Krish S","owner_url":"/insider/0001298709","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3357.0,"shares_display":"3,357","price_per_share":359.3861,"price_display":"359.39","price_state":"stated","total_value":1206459.1377,"total_display":"1,206,459.14","total_whole":"1,206,459","shares_owned_after":1356216.0,"shares_owned_after_display":"1,356,216","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9305438,"accession":"0001298709-26-000011","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001298709-26-000011","line_url":"/filing/0001298709-26-000011#line-7","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298709","owner_name":"Krishnan Krish S","owner_display_name":"Krishnan Krish S","owner_url":"/insider/0001298709","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2266.0,"shares_display":"2,266","price_per_share":360.463,"price_display":"360.46","price_state":"stated","total_value":816809.158,"total_display":"816,809.16","total_whole":"816,809","shares_owned_after":1353950.0,"shares_owned_after_display":"1,353,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9305437,"accession":"0001298709-26-000011","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001298709-26-000011","line_url":"/filing/0001298709-26-000011#line-8","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298709","owner_name":"Krishnan Krish S","owner_display_name":"Krishnan Krish S","owner_url":"/insider/0001298709","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1214.0,"shares_display":"1,214","price_per_share":361.6091,"price_display":"361.61","price_state":"stated","total_value":438993.4474,"total_display":"438,993.45","total_whole":"438,993","shares_owned_after":1352736.0,"shares_owned_after_display":"1,352,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9305436,"accession":"0001298709-26-000011","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001298709-26-000011","line_url":"/filing/0001298709-26-000011#line-9","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298709","owner_name":"Krishnan Krish S","owner_display_name":"Krishnan Krish S","owner_url":"/insider/0001298709","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2010.0,"shares_display":"2,010","price_per_share":362.6504,"price_display":"362.65","price_state":"stated","total_value":728927.304,"total_display":"728,927.30","total_whole":"728,927","shares_owned_after":1350726.0,"shares_owned_after_display":"1,350,726","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9305435,"accession":"0001298709-26-000011","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001298709-26-000011","line_url":"/filing/0001298709-26-000011#line-10","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298709","owner_name":"Krishnan Krish S","owner_display_name":"Krishnan Krish S","owner_url":"/insider/0001298709","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":573.0,"shares_display":"573","price_per_share":363.3424,"price_display":"363.34","price_state":"stated","total_value":208195.1952,"total_display":"208,195.20","total_whole":"208,195","shares_owned_after":1350153.0,"shares_owned_after_display":"1,350,153","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9305434,"accession":"0001298709-26-000011","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001298709-26-000011","line_url":"/filing/0001298709-26-000011#line-11","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298709","owner_name":"Krishnan Krish S","owner_display_name":"Krishnan Krish S","owner_url":"/insider/0001298709","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1358.0,"shares_display":"1,358","price_per_share":364.4794,"price_display":"364.48","price_state":"stated","total_value":494963.0252,"total_display":"494,963.03","total_whole":"494,963","shares_owned_after":1348795.0,"shares_owned_after_display":"1,348,795","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9305433,"accession":"0001298709-26-000011","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001298709-26-000011","line_url":"/filing/0001298709-26-000011#line-12","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298709","owner_name":"Krishnan Krish S","owner_display_name":"Krishnan Krish S","owner_url":"/insider/0001298709","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":847.0,"shares_display":"847","price_per_share":365.4163,"price_display":"365.42","price_state":"stated","total_value":309507.6061,"total_display":"309,507.61","total_whole":"309,508","shares_owned_after":1347948.0,"shares_owned_after_display":"1,347,948","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9305432,"accession":"0001298709-26-000011","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001298709-26-000011","line_url":"/filing/0001298709-26-000011#line-13","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298709","owner_name":"Krishnan Krish S","owner_display_name":"Krishnan Krish S","owner_url":"/insider/0001298709","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":405.0,"shares_display":"405","price_per_share":366.5567,"price_display":"366.56","price_state":"stated","total_value":148455.4635,"total_display":"148,455.46","total_whole":"148,455","shares_owned_after":1347543.0,"shares_owned_after_display":"1,347,543","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null}],"n_transactions":13,"line_constants":{"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true},"provenance":{"source_pass":"Layline","parse_status":"parsed","schema_version":null,"retrieved_at":"2026-09-05T05:24:49.724574+00:00","retrieved_label":"2026-09-05 05:24 UTC","primary_document":"https://www.sec.gov/Archives/edgar/data/1711279/0001298709-26-000011-index.htm","accepted_at":"2026-09-04T19:14:09+00:00","accepted_label":"2026-09-04 19:14 UTC"},"related":[{"accession":"0001298711-26-000009","url":"/filing/0001298711-26-000009","form_type":"4","issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_name_source":null,"issuer_ticker":"KRYS","issuer_url":"/issuer/0001711279","period_of_report":"2026-09-04","filed_date":"2026-09-04","acceptance_dt":"2026-09-04T19:15:49+00:00","acceptance_label":"2026-09-04 19:15 UTC","ingested_at":"2026-09-05T05:24:49.724574+00:00","ingested_label":"2026-09-05 05:24 UTC","schema_version":null,"source":"Layline","parse_status":"parsed","parse_ok":true,"edgar_url":"https://www.sec.gov/Archives/edgar/data/1711279/0001298711-26-000009-index.htm","day_url":"/filings/2026-09-04"}],"related_rule":"Other filings held for the same issuer and the same period of report. This is a heuristic match, not an authoritative amendment link: the store holds no 4/A-to-original relation and the catalog does not invent one.","canonical_url":"https://ebomi.com/filing/0001298709-26-000011","retrieved_at":"2026-09-05T12:32:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-09-04","last_ingest":"2026-09-05T05:24:49.724574+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}